| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 2] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続2] |
1438851-35-4 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 3] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続3] |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続4] |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevantolol Hydrochloride |
ベバントロール塩酸塩 |
42864-78-8 |
C20H27NO4▪HCl |
381.89
|
|
[日本上市数据][FDA GSRS]
|
| Bevonium Methylsulfate |
メチル硫酸ベボニウム |
5205-82-3 |
C23H31NO7S |
465.57
|
|
[日本上市数据][FDA GSRS]
|
| Bexarotene |
ベキサロテン |
153559-49-0 |
C24H28O2 |
348.48
|
|
[日本上市数据][FDA GSRS]
|
| Bezafibrate |
ベザフィブラート |
41859-67-0 |
C19H20ClNO4 |
361.82
|
|
[日本上市数据][FDA GSRS]
|
| Bezlotoxumab (Genetical Recombination) |
ベズロトクスマブ(遺伝子組換え) |
1246264-45-8 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Biapenem |
ビアペネム |
120410-24-4 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bicalutamide |
ビカルタミド |
90357-06-5 |
C18H14F4N2O4S |
430.37
|
|
[日本上市数据][FDA GSRS]
|
| Bicozamycin |
ビコザマイシン |
38129-37-2 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bictegravir Sodium |
ビクテグラビルナトリウム |
1807988-02-8 |
C21H17F3N3NaO5 |
471.36
|
|
[日本上市数据][FDA GSRS]
|
| Bifemelane Hydrochloride |
塩酸ビフェメラン |
62232-46-6 |
C18H23NO▪HCl |
305.85
|
|
[日本上市数据][FDA GSRS]
|
| Bifonazole |
ビホナゾール |
60628-96-8 |
C22H18N2 |
310.39
|
|
[日本上市数据][FDA GSRS]
|
| Bilastine |
ビラスチン |
202189-78-4 |
C28H37N3O3 |
463.61
|
|
[日本上市数据][FDA GSRS]
|
| Bimagrumab (Genetical Recombination) |
ビマグルマブ(遺伝子組換え) |
1356922-05-8 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bimatoprost |
ビマトプロスト |
155206-00-1 |
C25H37NO4 |
415.57
|
|
[日本上市数据][FDA GSRS]
|
| Bimekizumab (Genetical Recombination) |
ビメキズマブ(遺伝子組換え) |
1418205-77-2 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Binimetinib |
ビニメチニブ |
606143-89-9 |
C17H15BrF2N4O3 |
441.23
|
|
[日本上市数据][FDA GSRS]
|
| Bintrafusp Alfa (Genetical Recombination) |
ビントラフスプ アルファ(遺伝子組換え) |
1918149-01-5 |
|
|
|
[日本上市数据][FDA GSRS]
|